Many breast-cancer patients receive unnecessary treatment for possible tumour spread after the removal of a primary tumour. Molecular profiling should offer more accurate predictions of who needs such treatment.
This is a preview of subscription content, log in via an institution to check access.
References
Golub, T. R. et al. Science 286, 531–537 (1999).
van't Veer, L. J. et al. Nature 415, 530–536 (2002).
Goldhirsch, A., Glick, J. H., Gelber, R. D. & Senn, H.-J. J. Natl Cancer Inst. 90, 1601–1608 (1998).
National Institutes of Health Consensus Development Panel J. Natl Cancer Inst. 93, 979–989 (2001).
McGuire, W. L. J. Natl Cancer Inst. 83, 154–155 (1991).
Alizadeh, A. A. et al. Nature 403, 503–511 (2000).
Bittner, M. et al. Nature 406, 536–540 (2000).
Perou, C. M. et al. Nature 406, 747–752 (2000).
Khan, J. et al. Nature Med. 7, 673–679 (2001).
Aparicio, S. A., Caldas, C. & Ponder, B. Genome Biol. 1, 1021.1–1021.3 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caldas, C., Aparicio, S. The molecular outlook. Nature 415, 484–485 (2002). https://doi.org/10.1038/415484a
Issue Date:
DOI: https://doi.org/10.1038/415484a
- Springer Nature Limited
This article is cited by
-
A low variance error boosting algorithm
Applied Intelligence (2010)
-
Current potential and limitations of molecular diagnostic methods in head and neck cancer
European Archives of Oto-Rhino-Laryngology (2010)
-
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
BMC Cancer (2008)
-
Prädiktive Biomarker
Der Onkologe (2007)